Equity Overview
Price & Market Data
Price: $0.90
Daily Change: -$0.0321 / 3.57%
Daily Range: $0.86 - $0.96
Market Cap: $15,460,110
Daily Volume: 149,718
Performance Metrics
1 Week: -8.99%
1 Month: -9.64%
3 Months: -26.23%
6 Months: -75.54%
1 Year: -14.29%
YTD: -67.39%
Company Details
Employees: 6
Sector: Health technology
Industry: Medical specialties
Country:
Details
Nexalin Technology, Inc. designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy. It also offers Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. The company was incorporated in 2010 and is headquartered in Houston, Texas.